IP Library Granted Patent US 7,811,779
Granted Patent B2
US 7,811,779 · App. 10/594,898 · Granted Oct 12, 2010

Method of multiquantification for cholesterol of low-density lipoprotein

Assignee: Denka Seiken Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,811,779
App. No.
10/594,898
Granted
Oct 12, 2010
Kind
B2
Abstract

Provided is a method of stabilizing a reagent that allows simultaneous quantification of LDL cholesterol and total cholesterol by a single measurement by suppressing spontaneous color development thereof. A method of quantification for cholesterol in low density lipoprotein and total cholesterol in a biological sample by the single measurement comprises a first step of treating lipoproteins other than low density lipoprotein in the biological sample to generate hydrogen peroxide and a second step of converting the hydrogen peroxide obtained in the first step to a quinone dye and treating remaining low density lipoprotein and converting generated hydrogen peroxide to the quinone dye, where the quinone dye is not formed in the first step, and cholesterol in low density lipoprotein and total cholesterol are quantified from the amount of the quinone dye formed in the second step by the single measurement.

Claims (10)

1. A method of quantification for cholesterol in low density lipoprotein and total cholesterol simultaneously in a biological sample, comprising:

(i) adding a first reagent in the biological sample such that hydrogen peroxide is generated from lipoproteins other than low density lipoprotein; and

(ii) adding a second reagent to the biological sample of step (i) such that the hydrogen peroxide generated in step (i) is converted to a quinone dye and that additional hydrogen peroxide is generated from low density lipoprotein and converted to the quinone dye,

wherein the quantity of cholesterol in low density lipoprotein and the quantity of total cholesterol are determined by readings of absorbance at different time points following addition of the second reagent.

2. The method of claim 1 , wherein:

(a) said first reagent comprises a surfactant that acts on lipoproteins other than low density lipoprotein, a cholesterol esterase, a cholesterol oxidase and a compound that is either 4-aminoantipyrine or a phenolic or anilinic hydrogen donor compound;

(b) said first reagent does not comprise peroxidase; and

(c) said second reagent comprises a surfactant that acts on low density lipoprotein, a cholesterol esterase, a cholesterol oxidase, peroxidase and a compound that is either 4-aminoantipyrine or a phenolic or anilinic hydrogen donor compound but different from the compound in the said first reagent.

3. The method of claim 1 , wherein the first reading of absorbance is taken at 30 seconds after addition of said second reagent, and the second reading of absorbance is taken at 5 minutes after addition of said second reagent.

4. The method of claim 1 , wherein the measurement is performed by an automatic analyzer for clinical chemistry testing.

Assignments (2)
MERGER Recorded Oct 5, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 053976/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2006
From: MATSUMOTO, KEIKO; MATSUI, HIROSHI
To: DENKA SEIKEN CO., LTD.
Reel/Frame 018397/0867 →
Priority Claims (1)
JP 2004-106006 · Mar 31, 2004 · national
Continuity (1)
Related Publication 20070207515A1 · Sep 6, 2007